Senate
94th General Assembly (2023 Regular)
Passed
SB192
To Amend The Law Concerning Coverage Of Biosimlar Medical Products Under Step Therapy Protocols; And To Amend Exceptions To Step Therapy Protocols.
To Amend The Law Concerning Coverage Of Biosimlar Medical Products Under Step Therapy Protocols; And To Amend Exceptions To Step Therapy Protocols.
Bill Summary
To Amend The Law Concerning Coverage Of Biosimlar Medical Products Under Step Therapy Protocols; And To Amend Exceptions To Step Therapy Protocols.
Influence Proximity
1st Degree Direct
2nd Degree Shared
3rd Degree Extended
Network Filters
Bill Documents
Last Updated
Passed
Feb 27, 2023
Feb 27, 2023